Status of parasitological indicators and morbidity burden of onchocerciasis after years of successive implementation of mass distribution of ivermectin in selected communities of Yeki and Asosa districts, Ethiopia.

Publisher: BioMed Central Country of Publication: England NLM ID: 100968562 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2458 (Electronic) Linking ISSN: 14712458 NLM ISO Abbreviation: BMC Public Health Subsets: MEDLINE

Original Publication: London : BioMed Central, [2001-

Mass Drug Administration*; Endemic Diseases/*prevention & control ; Ivermectin/*therapeutic use ; Onchocerciasis/*drug therapy ; Onchocerciasis/*epidemiology; Adolescent ; Adult ; Cross-Sectional Studies ; Ethiopia/epidemiology ; Female ; Humans ; Male ; Middle Aged ; Morbidity ; Prevalence ; Program Evaluation ; Young Adult

Background: Control and elimination of onchocerciasis requires regular follow-up and evaluation of community directed treatment with ivermectin (CDTi) program implementation. This research was aimed to assess the epidemiological status of onchocerciasis in disease endemic communities of Asosa and Yeki districts of Ethiopia after 5 and 15 years of successive CDTi respectively, and to evaluate the decline in infection and morbidity burden.
Methods: A community-based cross-sectional study was conducted from August 2017 to January 2018 (i.e. within 2-7 months since the last treatment) using interview, physical and parasitological examinations. Pre-CDTi epidemiological data were obtained from studies conducted prior to the launch of CDTi.
Results: A total of 3002 individuals (1567 from Asosa and 1435 from Yeki) were included. No infection was detected from Yeki. In Asosa, the prevalence of infection was 1.6%. The geometric mean intensity of infection was 0.02 mf/mg of skin snip. The prevalence rates of dermatitis, depigmentation, nodule, and atrophy in Yeki were 33(2.3%), 57(4%), 37(2.6%) and 11(0.7%), respectively. The prevalence rates of papular dermatitis, depigmentation, palpable nodule, atrophy, and blindness in Asosa were 94(6%), 38(2.4%), 30(1.9%), 28(1.8%) and 2(0.1%), respectively. Five years of CDTi had significantly reduced prevalence and intensity of infection by 91.8% (p < 0.001) and 99.7% (p < 0.001), respectively. Moreover, CDTi reduced prevalence of papular dermatitis by 95.9% (p < 0.001), palpable nodule by 90.5% (p < 0.001), and atrophy by 30% (p = 0.6) in Yeki. Similarly, CDTi reduced prevalence of papular dermatitis by 88.6% (p < 0.001), depigmentation by 90.3% (p < 0.001), atrophy by 89.5% (p < 0.001), and blindness by 90% (p < 0.001) in Asosa.
Conclusions: Fifteen years of successive CDTi had brought the infection from high to zero in Yeki. However, thorough entomological and serological data need to be generated to ascertain whether complete interruption of parasite transmission has been attained, and for considerations of an evidence-based CDTi cessation. Five years of CDTi in Asosa has significantly reduced the infection and morbidity of onchocerciasis to very low level. We, hereby, recommend biannual CDTi to continue in Asosa and its surroundings until the infection transmission is fully interrupted.

ISRN Parasitol. 2013 Aug 25;2013:960168. (PMID: 27398386)
Parasit Vectors. 2016 Nov 14;9(1):581. (PMID: 27842567)
Bull World Health Organ. 1986;64(5):667-81. (PMID: 3492300)
Pathog Glob Health. 2014 Apr;108(3):123. (PMID: 24766334)
Philos Trans R Soc Lond B Biol Sci. 1990 Jun 30;328(1251):731-47, discussion 747-50. (PMID: 1976266)
Am J Trop Med Hyg. 2004 May;70(5):556-61. (PMID: 15155991)
Parasit Vectors. 2017 Aug 3;10(1):373. (PMID: 28774318)
Trans R Soc Trop Med Hyg. 1997 Jan-Feb;91(1):82-6. (PMID: 9093638)
Parassitologia. 1976 Jan-Dec;18(1-3):53-65. (PMID: 1032332)
Infect Dis Poverty. 2018 Apr 6;7(1):30. (PMID: 29628019)
Parasit Vectors. 2012 Feb 07;5:28. (PMID: 22313631)
Acta Trop. 1993 Aug;54(2):89-97. (PMID: 7902651)
Trop Geogr Med. 1986 Mar;38(1):33-7. (PMID: 3961907)
PLoS Negl Trop Dis. 2018 Mar 1;12(3):e0006312. (PMID: 29494606)
Ethiop Med J. 1989 Jul;27(3):121-8. (PMID: 2787743)
Ethiop Med J. 2002 Jul;40(3):259-69. (PMID: 12602250)
Infect Dis Poverty. 2016 Jun 27;5(1):66. (PMID: 27349645)
Parassitologia. 1991 Dec;33(2-3):187-97. (PMID: 1844511)
Ethiop Med J. 1999 Oct;37(4):223-36. (PMID: 11961873)
PLoS One. 2016 Mar 04;11(3):e0141029. (PMID: 26942910)
BMC Public Health. 2015 Jul 01;15:595. (PMID: 26130117)
Trans R Soc Trop Med Hyg. 1988;82(1):122-7. (PMID: 3176141)
Int Health. 2016 Mar;8 Suppl 1:i34-52. (PMID: 26940308)
Infect Dis Poverty. 2018 Mar 28;7(1):21. (PMID: 29587844)
Tropenmed Parasitol. 1979 Sep;30(3):345-62. (PMID: 575581)
Am J Trop Med Hyg. 2011 Dec;85(6):1041-9. (PMID: 22144441)
Ethiop Med J. 1993 Jul;31(3):191-200. (PMID: 8404884)
PLoS Negl Trop Dis. 2017 Jan 23;11(1):e0005314. (PMID: 28114304)
Infect Dis Poverty. 2018 Jul 3;7(1):63. (PMID: 29966535)
East Afr Med J. 2000 Feb;77(2):116-20. (PMID: 10774086)
Clin Infect Dis. 2016 Jun 1;62(11):1338-1347. (PMID: 27001801)
Br J Dermatol. 1993 Sep;129(3):260-9. (PMID: 8286222)
Trans R Soc Trop Med Hyg. 1992 May-Jun;86(3):277-80. (PMID: 1412652)
Acta Leiden. 1990;59(1-2):27-44. (PMID: 2378210)
Am J Trop Med Hyg. 1995 May;52(5):429-34. (PMID: 7771609)
Ethiop Med J. 2017;55(Suppl 1):3-14. (PMID: 28878427)
Parasit Vectors. 2015 Apr 02;8:202. (PMID: 25886166)
Lancet. 2007 Jun 16;369(9578):2021-2029. (PMID: 17574093)
PLoS Negl Trop Dis. 2015 Apr 21;9(4):e0003688. (PMID: 25897492)
Parasit Vectors. 2015 Dec 30;8:667. (PMID: 26715524)
Filaria J. 2003 Mar 24;2(1):8. (PMID: 12769825)
BMC Infect Dis. 2019 May 17;19(1):431. (PMID: 31101085)
Public Health. 2007 Mar;121(3):202-7. (PMID: 17241647)
Am J Epidemiol. 1973 Oct;98(4):283-8. (PMID: 4582701)
Ethiop Med J. 2002 Jan;40(1):19-27. (PMID: 12240564)
PLoS Negl Trop Dis. 2014 Sep 18;8(9):e3113. (PMID: 25233351)
BMC Med. 2007 May 23;5:9. (PMID: 17521449)
Am J Trop Med Hyg. 2013 Jul;89(1):51-7. (PMID: 23690554)
Parassitologia. 1990 Aug;32(2):237-44. (PMID: 2132435)
Trop Med Int Health. 2008 Sep;13(9):1196-203. (PMID: 18631308)
Indian J Public Health. 1993 Oct-Dec;37(4):135-7. (PMID: 8077003)
Am J Trop Med Hyg. 2016 Apr;94(4):906-11. (PMID: 26880774)
Bull World Health Organ. 2002;80(5):384-91. (PMID: 12077614)
Int Health. 2018 Mar 1;10(suppl_1):i60-i70. (PMID: 29471337)
J Parasitol Res. 2012;2012:748540. (PMID: 22970347)
Trop Med Int Health. 2006 Jul;11(7):1082-91. (PMID: 16827709)
Interdiscip Perspect Infect Dis. 2016;2016:6937509. (PMID: 27648069)
East Afr Med J. 1999 Nov;76(11):635-8. (PMID: 10734524)
Trop Med Parasitol. 1987 Dec;38(4):279-82. (PMID: 3441734)
PLoS Negl Trop Dis. 2014 Apr 24;8(4):e2824. (PMID: 24762816)
Trop Geogr Med. 1967 Dec;19(4):231-46. (PMID: 5585970)
Science. 1990 Oct 5;250(4977):116-8. (PMID: 2218502)
Parasit Vectors. 2014 May 26;7:241. (PMID: 24886747)
Trans R Soc Trop Med Hyg. 2004 Sep;98(9):520-8. (PMID: 15251400)
J Parasit Dis. 2012 Apr;36(1):10-8. (PMID: 23542576)
J Parasitol Res. 2013;2013:420928. (PMID: 23691275)
PLoS Negl Trop Dis. 2009 Jul 21;3(7):e497. (PMID: 19621091)
Infect Dis Poverty. 2019 Jul 4;8(1):60. (PMID: 31269966)
Acta Trop. 2015 Jun;146:114-8. (PMID: 25818324)
Ethiop Med J. 2017;55(Suppl 1):55-63. (PMID: 28878430)

Keywords: CDTi; Elimination; Ethiopia; Microfilariae; Morbidity; Onchocerciasis; Skin snip biopsy

70288-86-7 (Ivermectin)

Date Created: 20200814 Date Completed: 20200817 Latest Revision: 20200818

20240105

PMC7425055

10.1186/s12889-020-09344-7

32787813